Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 8, 2010 - Issue 12
Submit an article Journal homepage
188
Views
45
CrossRef citations to date
0
Altmetric
Theme: Thrombosis - Review

Angiotensin II, tissue factor and the thrombotic paradox of hypertension

Alessandro Celi Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy; Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy
,
Silvana Cianchetti Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy; Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy
,
Giulia Dell’Omo Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy; Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy
&
Roberto Pedrinelli Dipartimento Cardio Toracico e Vascolare, Università di Pisa, 56100 Pisa, Italy;[email protected]
Pages 1723-1729 | Published online: 10 Jan 2014

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sapha Shibeeb & Muneera Naseer Ahmad. (2021) Thrombotic and Hypercoagulability Complications of COVID-19: An Update. Journal of Blood Medicine 12, pages 785-793.
Read now

Articles from other publishers (44)

Lane M. SmithGraciela B. MentzMilo C. Engoren. (2023) Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis*. Critical Care Medicine 51:12, pages 1674-1684.
Crossref
Saira Rafaqat, Amber Khalid, Saira Riaz & Sana Rafaqat. (2023) Irregularities of Coagulation in Hypertension. Current Hypertension Reports.
Crossref
Sven Kurbel. (2023) Jerne's “immune network theory”, of interacting anti‐idiotypic antibodies applied to immune responses during COVID‐19 infection and after COVID‐19 vaccination. BioEssays.
Crossref
Jorge Gonçalves, Catarina D. Santos, Paula Fresco & Fernando Fernandez-Llimos. (2023) Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity. Revista Portuguesa de Cardiologia 42:4, pages 373-383.
Crossref
Sabrina Beal Pizzato, Paula Barros Terraciano, Pamela Zanon, Cristiana Palma Kuhl, Tuane Nerissa Alves Garcez, Eduardo Pandolfi Passos, Lucas Tirloni & Markus Berger. (2023) Estrogen depletion modulates aortic prothrombotic signaling in normotensive and spontaneously hypertensive female rats. Molecular and Cellular Endocrinology 561, pages 111827.
Crossref
Seda Ozkan & Afsin Ipekci. 2023. Biomarkers in Trauma, Injury and Critical Care. Biomarkers in Trauma, Injury and Critical Care 917 940 .
Daisuke Hasegawa, Young Im Lee, Narut Prasitlumkum, Lakshay Chopra, Kazuki Nishida, Robert L. Smith & Ryota Sato. (2022) Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis. The American Journal of Emergency Medicine 62, pages 69-77.
Crossref
Lina Jankauskaite, Mantas Malinauskas & Ausra Snipaitiene. (2022) Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor. Frontiers in Cardiovascular Medicine 9.
Crossref
Mardjono Tjahjadi, Sinatrya Caropeboka, Christian Permana, Krisandi Susanto & Eka Susanto. (2022) Long-Delayed Manifestation of COVID-19 Coagulopathy Presenting with Severe Cerebral Venous Thrombosis Causes Massive Brain Hemorrhage. Asian Journal of Neurosurgery 17:02, pages 342-346.
Crossref
Jonathan H. Chow, Erica D. Wittwer, Patrick M. Wieruszewski & Ashish K. Khanna. (2022) Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients. The Journal of Thoracic and Cardiovascular Surgery 163:4, pages 1407-1414.
Crossref
Qingguang Zhang, Shuang Ling, Kaili Hu, Jun Liu & Jin-Wen Xu. (2022) Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19). Biomedicine & Pharmacotherapy 148, pages 112718.
Crossref
Seda Ozkan & Afsin Ipekci. 2022. Biomarkers in Trauma, Injury and Critical Care. Biomarkers in Trauma, Injury and Critical Care 1 24 .
Murat Oz, Dietrich Ernst Lorke & Nadine Kabbani. (2021) A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacology & Therapeutics 221, pages 107750.
Crossref
Dun‐Feng Xu, Yu‐Jian Liu, Yan‐Fei Mao, Yan Wang, Chu‐Fan Xu, Xiao‐Yan Zhu & Lai Jiang. (2021) Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R‐dependent manner during sepsis. Journal of Cellular and Molecular Medicine 25:8, pages 4124-4135.
Crossref
Valeria Valente, Raffaele Izzo, Maria Virginia Manzi, Maria Rosaria De Luca, Emanuele Barbato & Carmine Morisco. (2021) Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention. Monaldi Archives for Chest Disease 91:2.
Crossref
M. Karolyi, E. Pawelka, S. Omid, H. Kelani, T. Mader, S. Baumgartner, H. Laferl, M. Traugott, T. Seitz, A. Zoufaly & C. Wenisch. (2020) Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients. European Journal of Clinical Microbiology & Infectious Diseases 40:3, pages 633-635.
Crossref
Maria Rosaria De Luca, Daniela Sorriento, Domenico Massa, Valeria Valente, Federica De Luise, Emanuele Barbato & Carmine Morisco. (2021) Effects of inhibition of the renin-angiotensin system on hypertension-induced target organ damage: clinical and experimental evidence. Monaldi Archives for Chest Disease 91:1.
Crossref
Jonathan H. Chow, Erik Strauss & Michael A. Mazzeffi. (2021) Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?. Journal of Cardiothoracic and Vascular Anesthesia 35:1, pages 59-60.
Crossref
Choongho Lee & Won Jun Choi. (2021) Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Archives of Pharmacal Research 44:1, pages 99-116.
Crossref
Rosemary Gan, Nicholas P. Rosoman, David J.E. Henshaw, Euan P. Noble, Peter Georgius & Nigel Sommerfeld. (2020) COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. Medical Hypotheses 144, pages 110024.
Crossref
Daniel Arthur Kasal, Andrea De Lorenzo & Eduardo Tibiriçá. (2020) COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart, Lung and Circulation 29:11, pages 1596-1602.
Crossref
Ankur Kalra, Edward S. Hawkins, Amy S. NowackiVardhmaan Jain, Alex Milinovich, Joshua SaefGeorge ThomasSurafel K. GebreselassieSadashiva S. Karnik, Lara JehiJames B. YoungLars G. Svensson, Mina K. Chung & Neil Mehta. (2020) Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers. Circulation: Cardiovascular Quality and Outcomes 13:10.
Crossref
István Szegedi, Rita Orbán-Kálmándi, László Csiba & Zsuzsa Bagoly. (2020) Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. Journal of Clinical Medicine 9:10, pages 3137.
Crossref
Vincenzo M. Monda, Francesca Porcellati, Felice Strollo & Sandro Gentile. (2020) ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?. Diabetes Therapy 11:9, pages 1909-1914.
Crossref
Nazzarena Labò, Hidetaka Ohnuki & Giovanna Tosato. (2020) Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection. Cells 9:7, pages 1583.
Crossref
Sergey Brankovich Bolevich, Peter Frantzevich Litvitsky, Sergei Vitalievich Grachev, Sergey Ivanovich Vorobyev, Alexandra Sergeevna Orlova, Marina Anatolievna Fokina, Alexei Alekseevich Novikov, Stephani Sergeevna Bolevich, Anastasia Yurievna Mikhaleva, Elena Mihailovna Morozova, Maria Konstantinovna Kartashova, Koka Hasbulatovna Yavlieva, Denis Vitalievich Gudanovich, Ivan Srejovic & Vladimir Jakovljevic. (2020) Fundamental Basis of COVID-19 Pathogenesis. Serbian Journal of Experimental and Clinical Research 21:2, pages 93-111.
Crossref
Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella & Gaetano Santulli. (2020) Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. Journal of Clinical Medicine 9:5, pages 1417.
Crossref
Kevin A. Bobeck, Arthur W. HoltzclawTara E. BrownPaul A. Clark. (2020) Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report. A&A Practice 14:6, pages e01221.
Crossref
Wan-Ting Hsu, Brandon Patrick GalmGregory SchrankTzu-Chun Hsu, Shih-Hao LeeJames Yeongjun Park & Chien-Chang Lee. (2020) Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis. Hypertension 75:2, pages 483-491.
Crossref
Wolfgang Miesbach & Michael Makris. (2020) COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and Applied Thrombosis/Hemostasis 26, pages 107602962093814.
Crossref
Elena Y. SenchenkovaJanice RussellAlper YildirimD. Neil GrangerFelicity N.E. Gavins. (2019) Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II–Induced Microvascular Dysfunction. Hypertension 73:4, pages 829-838.
Crossref
Marta Brambilla, Paolo Gelosa, Laura Rossetti, Laura Castiglioni, Chiara Zara, Paola Canzano, Elena Tremoli, Luigi Sironi & Marina Camera. (2018) Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats. Journal of Hypertension 36:6, pages 1360-1371.
Crossref
Elena Y. Senchenkova1, Janice Russell, Shantel A. Vital, Alper Yildirim1, A. Wayne Orr, D. Neil Granger & Felicity N. E. Gavins1. (2018) A critical role for both CD40 and VLA5 in angiotensin Il–mediated thrombosis and inflammation. The FASEB Journal 32:6, pages 3448-3456.
Crossref
Walkyria Oliveira Sampaio & Robson Augusto Souza dos Santos. 2018. Endothelium and Cardiovascular Diseases. Endothelium and Cardiovascular Diseases 203 211 .
Sivareddy Kotla, Nikhlesh K. Singh, Daniel Kirchhofer & Gadiparthi N. Rao. (2017) Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)-hydroxyeicosatetraenoic acid–induced monocyte trafficking. Journal of Biological Chemistry 292:36, pages 14885-14901.
Crossref
Dan Yang, Junjie Shao, Ruifeng Hu, Haimei Chen, Ping Xie & Chang Liu. (2017) Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice. Scientific Reports 7:1.
Crossref
Analina R. da Silva, Rodrigo A. Fraga-Silva, Nikolaos Stergiopulos, Fabrizio Montecucco & François Mach. (2015) Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. European Journal of Clinical Investigation 45:3, pages 274-287.
Crossref
. 2015. The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae. The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae 261 355 .
Rainer H. Straub. 2015. The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae. The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae 173 235 .
Elena Y. Senchenkova, Janice Russell, Charles T. Esmon & D. Neil Granger. (2014) Roles of Coagulation and Fibrinolysis in Angiotensin II-Enhanced Microvascular Thrombosis. Microcirculation 21:5, pages 401-407.
Crossref
Meng-yu Gao, Ling Chen, Lu Yang, Xiu Yu, Jun-ping Kou & Bo-yang Yu. (2014) Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells. Pharmacological Reports 66:3, pages 480-484.
Crossref
Craig J. Smith, Catherine B. Lawrence, Beatriz Rodriguez-Grande, Krisztina J. Kovacs, Jesus M. Pradillo & Adam Denes. (2013) The Immune System in Stroke: Clinical Challenges and Their Translation to Experimental Research. Journal of Neuroimmune Pharmacology 8:4, pages 867-887.
Crossref
Vibeke Bratseth, Alf-Åge Pettersen, Trine B Opstad, Harald Arnesen & Ingebjørg Seljeflot. (2012) Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment. Thrombosis Journal 10:1, pages 12.
Crossref
Arthur J. Chu. (2011) Tissue Factor, Blood Coagulation, and Beyond: An Overview. International Journal of Inflammation 2011, pages 1-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.